Inspire Medical Systems (INSP) PT Raised to $265 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts INSP Hot Sheet
Price: $68.80 +3.16%
Rating Summary:
8 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
8 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Inspire Medical Systems (NYSE: INSP) to $265.00 (from $260.00) while maintaining a Buy rating.
You May Also Be Interested In
- Helen of Troy (HELE) PT Raised to $29 at UBS on Q2 Beat
- RPM International (RPM) PT Lowered to $117 at KeyBanc
- LG Household & Health Care Ltd (0519000:KS) (LGHHF) PT Lowered to KRW262,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
